PubMed ID: 34720982 Author(s): Goebel C, Crabtree GS, Altaweel MM. Management of Iris Retraction Syndrome with Heterochromia and Retinal Detachment. Case Rep Ophthalmol. 2021 Sep 23;12(3):809-815. doi: 10.1159/000519148. eCollection 2021 Sep-Dec. PMID 34720982 Journal: Case …
All Posts
Opioid prescribing to preteen children undergoing ambulatory surgery in the United States.
PubMed ID: 33902922 Author(s): Cartmill RS, Yang DY, Walker BJ, Bradfield YS, Kille TL, Su RR, Kohler JE. Opioid prescribing to preteen children undergoing ambulatory surgery in the United States. Surgery. 2021 Sep;170(3):925-931. doi: 10.1016/j.surg.2021.03.043. …
2021 Multiphasic Phacoemulsification Course
In a return to regularly scheduled education programming that was disrupted by the COVID-19 pandemic, the Department of Ophthalmology and Visual Sciences (DOVS) hosted the 2021 Multiphasic Phacoemulsification Course on August 20-21 at the Health …
Implication of N-Methyl-d-Aspartate Receptor in Homocysteine-Induced Age-Related Macular Degeneration.
PubMed ID: 34502266 Author(s): Samra YA, Kira D, Rajpurohit P, Mohamed R, Owen LA, Shakoor A, Kim IK, DeAngelis MM, Sheibani N, Al-Shabrawey M, Tawfik A. Implication of N-Methyl-d-Aspartate Receptor in Homocysteine-Induced Age-Related Macular Degeneration. …
CLN-0500
A Randomized, Parallel-Arm, Active Control, Multicenter Study Assessing the Safety and Efficacy of Dextenza for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
ATMOSPHERE
A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD (ATMOSPHERE)
UNITY
A Phase 2a, Prospective, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Safety, Tolerability and Evidence of Activity of a Single Intravitreal Injection of UBX1325 in Patients with Diabetic Macular Edema
PEP
Patient Experience and Preference (PEP) Study in nAMD and DME
Teaming Up for Gene Therapy
*This article originally appeared in the McPherson Eye Research Institute Summer 2021 InSights Newsletter Millions of Americans currently battle inherited visual disorders, armed with very few therapeutic options. Recent advances in genome editing, which many believe …